Which has grown faster, ACRS or AQST?

Over the past five years, ACRS grew revenue faster — ACRS at a 4.39% CAGR versus AQST at -0.58%.

How have ACRS and AQST total returns compared?

Over the past 5 years, ACRS delivered -24.23% and AQST delivered 2.24% annualized total return. Past performance doesn't predict future results.

Aclaris Therapeutics, Inc. (ACRS) vs Aquestive Therapeutics, Inc. (AQST)

A side-by-side comparison of Aclaris Therapeutics, Inc. and Aquestive Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ACRS

Aclaris Therapeutics, Inc.

$596M

$4.27HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

AQST

Aquestive Therapeutics, Inc.

$573M

$4.57HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ACRS vs AQST

growth of $100 · dividends reinvested · last 8y

ACRS -78.5% (-17.5%/yr)AQST -71.5% (-14.5%/yr)AQST compounded faster over this window

ACRS AQST

ACRS vs AQST: by the numbers

•ACRS is the larger company ($596M vs $573M market cap).
•Both run net losses; AQST's is the smaller (-144.63% vs -921.50% net margin).
•ACRS grew revenue faster over the past five years (4.39% vs -0.58% CAGR).

Metrics side by side

Valuation

Metric	ACRS	AQST
P/S ratio	72.56	10.60
P/B ratio	4.79	N/A

Profitability

Metric	ACRS	AQST
Gross margin	73.28%	67.04%
Operating margin	-975.91%	-156.36%
Net margin	-921.50%	-144.63%
ROE	-60.79%	N/A
ROIC	-56.99%	-45.62%

Growth (annualized)

Metric	ACRS	AQST
Revenue CAGR (5Y)	4.39%	-0.58%
Total return CAGR (5Y)	-24.23%	2.24%

Frequently asked

Which has grown faster, ACRS or AQST?: Over the past five years, ACRS grew revenue faster — ACRS at a 4.39% CAGR versus AQST at -0.58%.
How have ACRS and AQST total returns compared?: Over the past 5 years, ACRS delivered -24.23% and AQST delivered 2.24% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ACRS analysis Full AQST analysis Interactive comparison tool

Dig into the metrics

Aclaris Therapeutics ROE Aquestive Therapeutics ROE Aclaris Therapeutics operating margin Aquestive Therapeutics operating margin Aclaris Therapeutics revenue growth Aquestive Therapeutics revenue growth Aclaris Therapeutics free cash flow Aquestive Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.